175 related articles for article (PubMed ID: 11924631)
1. Bone marrow transplants come of age. New hope for deadly diseases.
Meadows M
FDA Consum; 2000; 34(4):22-7. PubMed ID: 11924631
[No Abstract] [Full Text] [Related]
2. [Current status and issues in hematopoietic stem cell transplantation].
Harada M
Fukuoka Igaku Zasshi; 2007 Feb; 98(2):35-47. PubMed ID: 17396570
[No Abstract] [Full Text] [Related]
3. Primed marrow for autologous and allogeneic transplantation: a review comparing primed marrow to mobilized blood and steady-state marrow.
Elfenbein GJ; Sackstein R
Exp Hematol; 2004 Apr; 32(4):327-39. PubMed ID: 15050742
[TBL] [Abstract][Full Text] [Related]
4. Recent advances in allogeneic hematopoietic stem-cell transplantation.
Devine SM; Adkins DR; Khoury H; Brown RA; Vij R; Blum W; DiPersio JF
J Lab Clin Med; 2003 Jan; 141(1):7-32. PubMed ID: 12518165
[No Abstract] [Full Text] [Related]
5. The quest for a bone marrow donor--optimal or maximal HLA matching?
van Rood JJ; Oudshoorn M
N Engl J Med; 1998 Oct; 339(17):1238-9. PubMed ID: 9780345
[No Abstract] [Full Text] [Related]
6. Risk assessment in haematopoietic stem cell transplantation: stem cell source.
Urbano-Ispizua A
Best Pract Res Clin Haematol; 2007 Jun; 20(2):265-80. PubMed ID: 17448961
[TBL] [Abstract][Full Text] [Related]
7. [Clinical study of a new protocol for acute graft-versus host disease prophylaxis in HLA-haploidentical bone marrow transplantation (BMT)].
Ji SQ; Chen HR; Wang HX; Yan HM; Liu J; Xue M; Zhu L
Zhonghua Xue Ye Xue Za Zhi; 2003 Aug; 24(8):416-9. PubMed ID: 14642179
[TBL] [Abstract][Full Text] [Related]
8. Impact of AB0-blood group incompatibility on the outcome of recipients of bone marrow transplants from unrelated donors in the Japan Marrow Donor Program.
Kimura F; Sato K; Kobayashi S; Ikeda T; Sao H; Okamoto S; Miyamura K; Mori S; Akiyama H; Hirokawa M; Ohto H; Ashida H; Motoyoshi K;
Haematologica; 2008 Nov; 93(11):1686-93. PubMed ID: 18835834
[TBL] [Abstract][Full Text] [Related]
9. Sequential reduced- and full-intensity allografting using same donor in a child with chronic granulomatous disease and coexistent, significant comorbidity.
Nicholson JA; Wynn RF; Carr TF; Will AM
Bone Marrow Transplant; 2004 Dec; 34(11):1009-10. PubMed ID: 15489863
[No Abstract] [Full Text] [Related]
10. Improved results in marrow transplantation from unrelated donors. Genoa BMT Group.
Bacigalupo A; Lamparelli T; Barbanti M; Sacchi N; Battista Ferrara G; Pozzi S; Bregante S; Mordini N; Vitale V; Van Lint MT
Haematologica; 1999 Jun; 84 Suppl EHA-4():50-2. PubMed ID: 10907467
[No Abstract] [Full Text] [Related]
11. [Hematopoietic stem-cell transplantation in aplastic anemia].
Hernández-Rivera EG
Rev Invest Clin; 2005; 57(2):298-304. PubMed ID: 16524071
[TBL] [Abstract][Full Text] [Related]
12. Mesenchymal stem cells remain host-derived independent of the source of the stem-cell graft and conditioning regimen used.
Bartsch K; Al-Ali H; Reinhardt A; Franke C; Hudecek M; Kamprad M; Tschiedel S; Cross M; Niederwieser D; Gentilini C
Transplantation; 2009 Jan; 87(2):217-21. PubMed ID: 19155975
[TBL] [Abstract][Full Text] [Related]
13. Allogeneic bone marrow transplantation with non-T-cell-depleted marrow from two HLA-antigen-mismatched related donors.
Ogawa H; Ikegame K; Kawakami M; Taniguchi Y; Oka Y; Kawase I
Haematologica; 2004 Mar; 89(3):373-5. PubMed ID: 15020286
[TBL] [Abstract][Full Text] [Related]
14. Bone marrow transplantation.
Storb R; Santos GW
Transplant Proc; 1979 Mar; 11(1):1163-6. PubMed ID: 36699
[No Abstract] [Full Text] [Related]
15. Bone marrow transplantation in Thailand.
Issaragrisil S; Visuthisakchai S; Suvatte V; Chandanayingyong D; Piankijagum A
Transplant Proc; 1994 Aug; 26(4):2348-9. PubMed ID: 8066770
[No Abstract] [Full Text] [Related]
16. Rapamycin and T cell costimulatory blockade as post-transplant treatment promote fully MHC-mismatched allogeneic bone marrow engraftment under irradiation-free conditioning therapy.
Wu T; Sozen H; Luo B; Heuss N; Kalscheuer H; Lan P; Sutherland DE; Hering BJ; Guo Z
Bone Marrow Transplant; 2002 Jun; 29(12):949-56. PubMed ID: 12098061
[TBL] [Abstract][Full Text] [Related]
17. Bone marrow harvesting for malignant disease.
Maitland JA; Treleaven JG; Clink HM
Eur J Surg Oncol; 1986 Mar; 12(1):5-8. PubMed ID: 3514274
[No Abstract] [Full Text] [Related]
18. Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation.
Strober S
Blood Cells Mol Dis; 2008; 40(1):48-54. PubMed ID: 17827036
[TBL] [Abstract][Full Text] [Related]
19. Hematopoietic cell transplantation from an HLA-mismatched familial donor is feasible without ex vivo-T cell depletion after reduced-intensity conditioning with busulfan, fludarabine, and antithymocyte globulin.
Lee KH; Lee JH; Lee JH; Kim DY; Kim SH; Shin HJ; Lee YS; Kang YA; Seol M; Ryu SG
Biol Blood Marrow Transplant; 2009 Jan; 15(1):61-72. PubMed ID: 19135944
[TBL] [Abstract][Full Text] [Related]
20. Reducing transplant-related mortality after allogeneic hematopoietic stem cell transplantation.
Bacigalupo A; Sormani MP; Lamparelli T; Gualandi F; Occhini D; Bregante S; Raiola AM; di Grazia C; Dominietto A; Tedone E; Piaggio G; Podesta M; Bruno B; Oneto R; Lombardi A; Frassoni F; Rolla D; Rollandi G; Viscoli C; Ferro C; Garbarino L; Van Lint MT
Haematologica; 2004 Oct; 89(10):1238-47. PubMed ID: 15477210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]